Félix Tshisekedi & Gilead Sciences

Félix Tshisekedi: Félix Tshisekedi, President of the Democratic Republic of the Congo, called for calm and vigilance after holding a crisis meeting regarding the Ebola outbreak.

Gilead Sciences: Gilead Sciences is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.

Félix Tshisekedi: President of DRC; facing criticism over response and political use of health measures.

Gilead Sciences: Supplying remdesivir for clinical trials; potential positive impact if treatment proves effective.

Félix Tshisekedi: As President of the Democratic Republic of the Congo>>>, Félix Tshisekedi>>> is involved in discussions with the World Health Organization>>> regarding the country's Ebola outbreak and the government's response.

Gilead Sciences: Gilead Sciences' antiviral drug remdesivir and experimental drug obeldesivir are being prioritized for clinical trials to treat or prevent the Bundibugyo ebolavirus, indicating its significant role in potential therapies.

Félix Tshisekedi: As President of the Democratic Republic of the Congo>>>, Félix Tshisekedi>>> is involved in discussions with the World Health Organization>>> regarding the country's Ebola outbreak and the government's response.

Gilead Sciences: Gilead Sciences' experimental oral COVID antiviral drug, Obeldesivir, is being considered for use as a preventative treatment for Ebola contacts, under strict protocol.

Félix Tshisekedi: President of DRC; engaged in US minerals partnership talks.

Gilead Sciences: Developed obeldesivir, the antiviral being tested in the EBO-PEP trial.